Work

A conversation with P. Roy Vagelos

Year: 2014
Type: article
Abstract: The biochemist P. Roy Vagelos (Figure ​(Figure1)1) is best known for leading Merck for 20 years, first as President of research and then later as CEO and Chairman of the Board. In his time at Merck, he revolutionized the way the company approached drug discovery, introduced the first statins to market, and organized the donation of ivermectin, the agent for control of river blindness, to any and all who need it for as long as it is needed. The full interview, including a story about almost being court-martialed, can be seen on the JCI website, http://www.jci.org/kiosk/cgm.
Language: English
Open Access status: bronze
OpenAlex ID: W1977438987
FWCI: 1.435
Cites:
Cited by: 7
Related to: 10